The FDA granted approval Oct. 27 for toripalimab-tpzi, a new drug therapy for head and neck cancer patients.
The FDA granted approval Oct. 27 for toripalimab-tpzi, a new drug therapy for head and neck cancer patients.
Copyright © 2024 | WordPress Theme by MH Themes